PTGS2 and head and neck squamous cell carcinoma: The role of cyclooxygenase-2 (COX-2) in hypopharyngeal CSC resistance was investigated by Saito et al., who reported an inverse correlation between COX-2 expression in HNSCC specimens and pathological response to induction chemotherapy.